Total Payments
$1.3M
2024 Payments
$265,420
Companies
14
Transactions
706
Payment Breakdown by Category
Other$897,594 (69.2%)
Consulting$233,426 (18.0%)
Travel$149,640 (11.5%)
Food & Beverage$14,499 (1.1%)
Research$1,275 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $877,192 | 174 | 67.7% |
| Consulting Fee | $233,426 | 58 | 18.0% |
| Travel and Lodging | $149,640 | 309 | 11.5% |
| Honoraria | $20,402 | 4 | 1.6% |
| Food and Beverage | $14,499 | 157 | 1.1% |
| Unspecified | $1,275 | 4 | 0.1% |
Payments by Type
General
$1.3M
702 transactions
Research
$1,275
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $646,666 | 237 | $0 (2024) |
| GENZYME CORPORATION | $388,575 | 292 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $94,401 | 85 | $0 (2020) |
| AstraZeneca UK Limited | $53,426 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $36,753 | 11 | $0 (2024) |
| CSL Behring | $23,450 | 12 | $0 (2019) |
| ModernaTX, Inc. | $17,848 | 11 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $8,393 | 4 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $7,110 | 3 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $5,652 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $265,420 | 89 | SANOFI-AVENTIS U.S. LLC ($260,470) |
| 2023 | $196,938 | 102 | SANOFI-AVENTIS U.S. LLC ($113,530) |
| 2022 | $141,991 | 56 | SANOFI-AVENTIS U.S. LLC ($125,450) |
| 2021 | $109,318 | 41 | SANOFI-AVENTIS U.S. LLC ($93,463) |
| 2020 | $128,818 | 97 | GENZYME CORPORATION ($95,902) |
| 2019 | $169,314 | 103 | GENZYME CORPORATION ($97,854) |
| 2018 | $198,934 | 144 | GENZYME CORPORATION ($160,990) |
| 2017 | $85,700 | 74 | Novartis Pharmaceuticals Corporation ($41,352) |
All Payment Transactions
706 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $2,370.00 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,099.00 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $352.84 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $288.00 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $238.42 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $185.55 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $82.54 | General |
| Category: Oncology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13,117.00 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $1,089.02 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $393.92 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $379.35 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $150.31 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $147.30 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 10/08/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,099.00 | General |
| Category: Oncology | ||||||
| 10/08/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $142.76 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13,117.00 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $890.22 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $874.96 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | In-kind items and services | $667.43 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Travel and Lodging | Cash or cash equivalent | $208.02 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $116.84 | General |
| Category: Oncology | ||||||
| 10/07/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | Cash or cash equivalent | $57.74 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Al | SANOFI-AVENTIS U.S. LLC | $1,275 | 4 |
About Dr. Dorry Segev, M.D
Dr. Dorry Segev, M.D is a Surgery healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326071945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dorry Segev, M.D has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $265,420 received in 2024. These payments were reported across 706 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($877,192).
Ad
Practice Information
- Specialty Surgery
- Location Baltimore, MD
- Active Since 07/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1326071945
Products in Payments
- THYMOGLOBULIN (Biological) $597,048
- THYMOGLOBULIN (Drug) $321,715
- NO PRODUCT DISCUSSED (Drug) $20,531
- Moderna Covid-19 Vaccine (Biological) $17,848
- REZUROCK (Drug) $15,945
- UVADEX (Drug) $9,991
- EVUSHELD (Drug) $9,742
- Envarsus (Drug) $5,115
- DEFITELIO (Drug) $4,860
- Defitelio (Drug) $2,250
- UVADEX METHOXSALEN STERILE SOLUTION (Drug) $372.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Baltimore
Thomas Swope, Md, MD
Surgery — Payments: $1.1M
Surgery $1.1M
Dr. Alisa Coker, M.d, M.D
Surgery — Payments: $608,746
Surgery $608,746
Dr. John Ledonne, M.d, M.D
Surgery — Payments: $514,756
Surgery $514,756
Robert Montgomery, M.d, M.D
Surgery — Payments: $158,497
Surgery $158,497
Dr. Christopher You, M.d, M.D
Surgery — Payments: $134,200
Surgery $134,200
Martin Makary, M.d., M.p.h, M.D., M.P.H
Surgery — Payments: $130,421
Surgery $130,421